About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
https://weizmann-usa.org/news-media/news-releases/toward-an-ultra-personalized-therapy-for-melanoma/
Sep 12, 2018...
T cells (red) attacking melanoma cells (green). The neo-antigen-specific T cells in this image are especially effective at killing cancer cells
REHOVOT, IS ... Read more
Oct 16, 2019... October is National Breast Cancer Awareness Month, and people across the world are helping raise awareness and support through runs, walks, events – and, at the ... Read more
Jul 25, 2018... Response to treatment in cancer cells: The abundance of the EGFR (top row) and HER2 (bottom row) receptors is reduced when the cells are exposed to triple thera ... Read more
https://weizmann-usa.org/news-media/in-the-news/why-cancer-drugs-may-work-better-while-you-sleep/
Oct 09, 2014... It’s news to no one that your body works differently when you’re awake and when you’re sleeping. But could the different states also affect how your body proces ... Read more
https://weizmann-usa.org/news-media/in-the-news/the-transformation/
Sep 15, 2014...
An experimental new drug can make some leukemic cells mature into healthier ones. Illustration by Brian Stauffer
For almost thirty years, William Kuhens wo ... Read more
May 03, 2012... Do you know that skin cancer is the most common form of cancer? And that it’s on the rise, with increased incidence over the last 30 years? In fact, the America ... Read more
Mar 24, 2019...
Trial-In CEO Nir Erez. (photo credit: Courtesy)
Working in the field of oncology was a case of love at first sight for Weizmann Institute of Science gradua ... Read more
https://weizmann-usa.org/news-media/in-the-news/ema-approves-steba-s-prostate-cancer-drug/
Sep 25, 2017...
Raphael and Fabrice Harari
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended by a majority of 29-2 ... Read more
Sep 17, 2018... September is both Prostate Cancer Awareness Month and Ovarian Cancer Awareness Month in the U.S., where prostate cancer is the most common cancer (after skin ca ... Read more
https://weizmann-usa.org/news-media/news-releases/predicting-immunotherapy-success/
Feb 18, 2020... REHOVOT, ISRAEL—February 18, 2020—One of the frustrations with anti-cancer therapy is that no one drug fits all: Most work well in some people but have little e ... Read more
©2024 American Committee for the Weizmann Institute of Science
